Effectiveness of Intralesional Bleomycin Sclerotherapy for Lymphangioma in Children

Fiaz, Mudassar

doi:10.18535/jmscr/v6i1.03

Cited by 1 publication

(1 citation statement)

References 11 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was no significant difference observed regarding age, sex and site of lymphangioma between both groups with p-value >0.05. A study by Fiaz M et al [12] reported that neck was the commonest site of lymphangioma found in 63.3% followed by axilla, face and trunk 13.3%, 13.3% and 10%.…”

Section: Discussionmentioning

confidence: 97%

Compare the Outcomes of Sclerotherapy with Bleomycin Versus Surgical Resection in Children with Cystic Hygroma

Khan¹,

Zada²,

Shah³

et al. 2021

PJMHS

View full text Add to dashboard Cite

Objective: To compare the outcomes of sclerotherapy with bleomycin versus surgical resection in children with cystic hygroma. Study Design: Comparative/Observational Place and Duration: Paediatric department of Khalifa Gul Nawaz Medical Teaching Institute, Bannu for 20 months duration from 1st August 2019 to 31st March 2021. Methods: Total 40 patients of both genders with ages 1 month to 15 years presented with cystic hygroma were included in this study. Patients' detailed demographics were recorded after written consent from parents/guardians. Patients were divided in to two groups’ i.e. Group A consist of 20 patients and received sclerotherapy with intra-lesional bleomycin and Group B consist of 20 patients received surgical excision. Outcomes were analyzed at post-procedure 3 and 6 months post-procedure and compared the findings between both groups. Results: There was no significant difference observed between both groups regarding age, gender and site of lymphangioma p-value >0.05. In Group A 15 (75%) patients showed excellent results, 3 (15%) patients showed good results and 2 (10%) showed poor results. In Group B 13 (65%) showed excellent results, 4 (20%) showed good results and 3 (15%) showed poor results. At final follow-up there were no patient with recurrence in Group A while in Group B 2 (10%) patients had recurrence, Conclusion: It is concluded that sclerosing treatment with bleomycin is a safe and effective treatment modality with no recurrence as compared to surgical rexection. Keywords: Cystic Hygroma, Sclerotherapy, Bleomycin, Surgery, Recurrence

show abstract

Section: Discussionmentioning

confidence: 97%